Michelle Fleury

Michelle Fleury has a background in microbiology and immunology with a PhD from Boston University School of Medicine. Michelle has extensive experience in research and scientific roles, including positions at Abata Therapeutics, TCR² Therapeutics Inc., Obsidian Therapeutics, and Biogen Idec. Michelle's work involves testing drug constructs for unwanted side effects, differentiating induced pluripotent stem cells, creating novel salt forms, and supporting vaccine concept development. Michelle's dedication and contributions in the field have solidified their as an accomplished Associate Director of Research and Principal Scientist.